Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.
Linke, Axel; Chandrasekhar, Jaya; Sartori, Samantha; Lefevre, Thierry; van Belle, Eric; Schaefer, Ulrich; Tchetche, Didier; Sardella, Gennaro; Webb, John; Colombo, Antonio; Windecker, Stephan; Vogel, Birgit; Farhan, Serdar; Sorrentino, Sabato; Sharma, Madhav; Snyder, Clayton; Asgar, Anita; Dumonteil, Nicolas; Tamburino, Corrado; Hink, Ulrich; Violini, Roberto; Stella, Pieter; Bernstein, Debra; Deliargyris, Efthymios; Hengstenberg, Christian; Baber, Usman; Mehran, Roxana; Anthopoulos, Prodromos; Dangas, George.
Catheter Cardiovasc Interv
; 90(6): 1016-1026, 2017 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-28498562
[Degenerative Aortic Stenosis: Modern View on Development, Course, and Management].
Management of Nonagenarian Patients With Severe Aortic Stenosis: The Role of Comorbidity.
Use of Historical Surgical Times to Predict Duration of Primary Aortic Valve Replacement.
Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.
Aortic Valve Bioprostheses: Leaflet Immobility and Valve Thrombosis.
Transcatheter Aortic Valve Implantation in Intermediate Surgical Risk Patients With Severe Aortic Stenosis: A Systematic Review and Meta-Analysis.
Hyper-Response to Clopidogrel in Japanese Patients Undergoing Transcatheter Aortic Valve Implantation.
Transcatheter aortic valve implantation and surgical aortic valve replacement among hospitalized patients with and without type 2 diabetes mellitus in Spain (2014-2015).
Predictors of Rapid Progression and Clinical Outcome of Asymptomatic Severe Aortic Stenosis.
Transcatheter Aortic Valve Replacement: 2015 in Review.